Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides.

Literature DB >> 2918552

Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides.

D Iliopoulos¹, C Ernst, Z Steplewski, J A Jambrosic, U Rodeck, M Herlyn, W H Clark, H Koprowski, D Herlyn.

Abstract

A human melanoma variant cell line was obtained from a lung metastasis that arose spontaneously after we inoculated melanoma cells sc into a nude mouse. In this model, IgG2a monoclonal antibody (MAb) ME 36.1 defining the GD2/GD3 gangliosides inhibited melanoma growth at the primary site and metastatic spread of the cells, whereas an IgG1 variant of MAb ME 36.1 inhibited lung metastasis formation only. Possible mechanisms of antitumor effects of MAb ME 36.1 are discussed.

Entities: CellLine Disease Gene Species

Mesh：

Substances：

Year: 1989 PMID： 2918552 DOI： 10.1093/jnci/81.6.440

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

25 in total

Review 1. Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.

Authors: Zulmarie Perez Horta; Jacob L Goldberg; Paul M Sondel
Journal: Immunotherapy Date: 2016-09 Impact factor: 4.196

2. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.

Authors: Kazunori Hamamura; Keiko Furukawa; Takanori Hayashi; Takeshi Hattori; Junji Nakano; Hideyuki Nakashima; Tetsuya Okuda; Hideki Mizutani; Hisashi Hattori; Minoru Ueda; Takeshi Urano; Kenneth O Lloyd; Koichi Furukawa
Journal: Proc Natl Acad Sci U S A Date: 2005-07-22 Impact factor: 11.205

3. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines.

Authors: A Vultur; J Villanueva; C Krepler; G Rajan; Q Chen; M Xiao; L Li; P A Gimotty; M Wilson; J Hayden; F Keeney; K L Nathanson; M Herlyn
Journal: Oncogene Date: 2013-04-29 Impact factor: 9.867

4. Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains.

Authors: Yuki Ohkawa; Sayaka Miyazaki; Kazunori Hamamura; Mariko Kambe; Maiko Miyata; Orie Tajima; Yuhsuke Ohmi; Yoshio Yamauchi; Koichi Furukawa; Keiko Furukawa
Journal: J Biol Chem Date: 2010-06-25 Impact factor: 5.157

5. Enhancing the evaluation of PI3K inhibitors through 3D melanoma models.

Authors: Batool Shannan; Quan Chen; Andrea Watters; Michela Perego; Clemens Krepler; Rakhee Thombre; Ling Li; Geena Rajan; Scott Peterson; Phyllis A Gimotty; Melissa Wilson; Katherine L Nathanson; Tara C Gangadhar; Lynn M Schuchter; Ashani T Weeraratna; Meenhard Herlyn; Adina Vultur
Journal: Pigment Cell Melanoma Res Date: 2016-03-21 Impact factor: 4.693

Review 6. Human melanoma: development and progression.

Authors: M Herlyn
Journal: Cancer Metastasis Rev Date: 1990-09 Impact factor: 9.264

7. An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF^V600E inhibitor-resistant metastatic melanoma cells.

Authors: Shaun Martin; Aleksandra M Dudek-Peric; Abhishek D Garg; Heleen Roose; Seyma Demirsoy; Sofie Van Eygen; Freya Mertens; Peter Vangheluwe; Hugo Vankelecom; Patrizia Agostinis
Journal: Autophagy Date: 2017-07-19 Impact factor: 16.016